Hematology Analyzers - Eglin AF, Florida
ID: HT9408-25-HemaAnalyzersType: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYSAN ANTONIO, TX, 78230, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE (6632)

Original Source

https://sam.gov/opp/09331b135c7848778da181533096620f/view
Timeline
    Description

    The Defense Health Agency (DHA) is conducting market research to identify potential sources for providing and delivering Hematology Analyzers at Eglin Air Force Base, Florida. The procurement aims to enhance healthcare capabilities within the military medical system by acquiring two integrated hematology analyzers that comply with Department of Defense specifications and meet rigorous accuracy standards as defined by the Clinical Laboratory Improvement Act. Interested firms are encouraged to submit their capabilities and qualifications by May 1, 2025, to Mr. Robby Brinkmann at robert.t.brinkmann.civ@health.mil, with the possibility of the contract being set aside for small businesses based on responses received.

    Point(s) of Contact
    Robby Brinkmann
    robert.t.brinkmann.civ@health.mil
    Marcus Mattingly
    marcus.h.mattingly.civ@health.mil
    Files
    Title
    Posted
    STATEMENT OF WORK Hemo Analzyer Draft.docx
    The document outlines a Statement of Work for the provision, maintenance, and operation of Hematology Analyzers at Eglin Air Force Base, Florida. It details the objectives, performance requirements, installation protocols, and support services necessary for high-standard laboratory operations. The contractor is required to deliver two integrated hematology analyzers, comply with Department of Defense specifications, and ensure all equipment meets rigorous accuracy standards defined by the Clinical Laboratory Improvement Act. Essential features include automated verification systems, real-time monitoring capabilities, and an interface with MHS GENESIS for patient data integration. Additionally, the contractor must provide training for government staff, emergency technical support, and adherence to health privacy regulations under HIPAA. The document stresses the importance of operational readiness, quality assurance, and thorough documentation for compliance and performance validation. This statement serves as a federal request for proposals aimed at enhancing healthcare capabilities within the military medical system, ensuring adherence to standards of quality and privacy in handling sensitive health information.
    Lifecycle
    Title
    Type
    Hematology Analyzers - Eglin AF, Florida
    Currently viewing
    Sources Sought
    Similar Opportunities
    The Medical Readiness Contracting Office West (MRCO -W) is issuing this Sources Sought for a cost-per-reportable-result agreement to conduct hematology testing for the CBC, Reticulocyte counts, and Body Fluid Count in support of the BAMC.
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO-W), is seeking sources for a cost-per-reportable-result agreement to conduct hematology testing, including CBC, Reticulocyte counts, and Body Fluid Counts, in support of the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement aims to provide fully automated hematology analyzers and associated reagents, consumables, and quality control materials to meet the laboratory's operational needs, with an annual testing volume of approximately 194,981 tests across various locations. This opportunity is critical for maintaining the laboratory's capacity to deliver timely and accurate hematological analyses, ensuring high-quality patient care. Interested vendors must submit their responses by 1:00 PM CST on December 29, 2025, and can direct inquiries to Medina L. Woodson at medina.l.woodson.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.
    Solicitation Integrated Immunoassay and Chemistry Analyzer Reagents and Consumables
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking proposals from Women-Owned Small Businesses (WOSB) for the procurement of an Integrated Immunoassay and Chemistry Analyzer, along with necessary reagents and consumables, for the Lyster Army Health Clinic located in Fort Rucker, Alabama. The contract will operate under a Cost-Per-Reportable-Result pricing model and requires the analyzer to perform a variety of assays, including Hemoglobin A1C and Alanine Aminotransferase, while ensuring compatibility with the DoD laboratory information system MHS Genesis. Proposals must be submitted by January 16, 2026, with all inquiries directed to the primary contact, MEDCOM, at karan.e.quiles.civ@health.mil, or the secondary contact, Fredicinda D. Jones, at fredicinda.d.jones.civ@health.mil. Interested vendors must also comply with stringent cybersecurity requirements as outlined by the Defense Health Agency, ensuring the protection of sensitive data throughout the contract lifecycle.
    Coagulation Analyzers for Naval Hospital Yokosuka and Branch Clinic Iwakuni
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking to procure three coagulation analyzers and associated reagents for the Naval Hospital Yokosuka and Branch Clinic Iwakuni in Japan. The analyzers must meet specific technical requirements, including Laboratory Information System connectivity, a Windows 11 user interface, and the capability to perform various coagulation tests, while adhering to size and power limitations due to laboratory constraints. These analyzers are critical for ensuring timely and accurate diagnostic capabilities in a military healthcare setting. Interested vendors should contact Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeff Collins at jeffrey.p.collins20.civ@health.mil for further details, with a delivery, installation, and validation deadline set for July 1, 2023.
    Chemistry Analyzers for Naval Hospital Yokosuka
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking to procure five chemistry analyzers for the Naval Hospital Yokosuka in Japan. The analyzers must meet specific technical requirements, including a Laboratory Information System with bidirectional interface capabilities, the ability to process various sample types, and features for critical value notifications, among others. These analyzers are crucial for efficient laboratory operations, enabling the hospital to manage a high volume of samples—up to 100,000 annually—while ensuring timely and accurate diagnostics. Interested vendors can reach out to Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeffrey Collins at JEFFREY.P.COLLINS20.CIV@HEALTH.MIL for further details.
    Sole Source - Urine Analyzers for NHCH
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking to procure automated urine laboratory analyzers and associated supplies for the United States Naval Health Clinic Hawaii (NHCH) and Branch Health Clinic Kaneohe Bay. This procurement includes reagents, quality control, maintenance, and consumables, specifically two automated urine analyzers, which are critical for enhancing diagnostic capabilities in military healthcare settings. The contract has been awarded as a firm-fixed-price, sole source to Beckman Coulter, Inc., following the Simplified Acquisition Procedures due to a lack of additional interest from other parties. For further inquiries, interested parties can contact Michelle Sanders at michelle.e.sanders6.civ@health.mil or by phone at 210-952-8481.
    6640--VISN 15 | Hematology instrumentation, reagents, and service | CPRR |
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contract Office 15 (VISN 15), is seeking qualified vendors to provide hematology instrumentation, reagents, and services under a Cost per Patient Reportable Result (CPRR) agreement. The procurement aims to replace existing XN analyzers with updated models that meet specific clinical performance standards, ensuring comprehensive laboratory capabilities across multiple VA Medical Centers. This initiative is critical for maintaining high-quality laboratory services, including the provision of continuously stocked inventory, emergency supply delivery, and equipment validation. Interested parties must submit their responses, including detailed documentation of technical expertise, to the Contract Specialist, Maria Riza R. Owen, via email by December 26, 2025, at 1:00 PM CST. All offerors must be registered in the System for Award Management (SAM) and comply with additional registration requirements for veteran-owned businesses.
    Defense Health Agency Data Governance Transforming the Data Landscape: A Strategic Imperative for Modern Healthcare in Support of Military Readiness
    Dept Of Defense
    The Defense Health Agency (DHA) is seeking proposals from qualified small businesses to provide contractor support for advancing enterprise data readiness and governance within the Military Health System. The primary objectives include developing a comprehensive baseline data inventory, establishing a centralized metadata repository, conducting an Analysis of Alternatives for an enterprise data catalog, and implementing automated metadata harvesting tools to enhance data accessibility and usability. This initiative is crucial for improving decision-making and operational efficiency in military healthcare, with a total contract value of $34 million and a performance period from January 30, 2026, to January 29, 2027, with options for additional 12-month periods. Interested parties should direct inquiries to Linda M. Walker or Andrea V. Rivas via email, and proposals must be submitted electronically by January 9, 2026.
    6640 - Beckman Coulter AU5800 series clinical chemistry analyzers consumable supplies
    Dept Of Defense
    The Department of Defense, specifically the Navy's Fleet Logistics Center Norfolk, is seeking information from qualified sources capable of providing consumable supplies for Beckman Coulter AU5800 series clinical chemistry analyzers. This request for information (RFI) aims to identify potential suppliers who can furnish new supplies, as detailed in the attached list, and emphasizes that only items with specified part numbers will be accepted, with no substitutes allowed. These supplies are critical for laboratory operations across various military drug testing laboratories located in Illinois, Florida, Maryland, Hawaii, and Texas. Interested vendors must submit their capability statements, including company information and Small Business status, via email to Jorge Candela at jorge.e.candelabocanegra.civ@us.navy.mil by 4:00 PM Eastern Time on December 22, 2025. This RFI is for market research purposes only and does not constitute a solicitation for proposals.
    LIMITED SOUCES JUSTIFICATION FOR ROCHE DIAGNOSTICS
    Dept Of Defense
    The Department of Defense, specifically the Naval Medical Center San Diego, is seeking to procure an automated clinical chemistry laboratory analyzer and associated supplies from Roche Diagnostics Corporation on a limited source basis. This procurement is essential to ensure uninterrupted patient care while transitioning to a new health information system, MHS Genesis, which requires the integration and validation of the new analyzer system. The estimated contract value is $749,000 for a six-month period, from January 10, 2023, to June 30, 2023, with the primary contact for inquiries being Dernell Wade at dernell.w.wade.civ@mail.mil or 702-881-8104.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.